Correction of a pathogenic gene mutation in human embryos.
about
Genome editing of human embryos: to edit or not to edit, that is the question.The Promise and Challenge of In Vivo Delivery for Genome Therapeutics.A transatlantic perspective on 20 emerging issues in biological engineering.Immunity to CRISPR Cas9 and Cas12a therapeutics.Regulatory and Scientific Advancements in Gene Therapy: State-of-the-Art of Clinical Applications and of the Supporting European Regulatory Framework.Genome Editing: The Recent History and Perspective in Cardiovascular Diseases.Correction of β-thalassemia mutant by base editor in human embryos.Addressing challenges in the clinical applications associated with CRISPR/Cas9 technology and ethical questions to prevent its misuse.CRISPR/Cas9 microinjection in oocytes disables pancreas development in sheep.Autonomy in Tension: Reproduction, Technology, and Justice.The Future of CRISPR Applications in the Lab, the Clinic and Society.The state of the art in stem cell biology and regenerative medicine: the end of the beginning.Domesticated, Genetically Engineered, and Wild Plant Relatives Exhibit Unintended Phenotypic Differences: A Comparative Meta-Analysis Profiling Rice, Canola, Maize, Sunflower, and Pumpkin.Assembly of CRISPR ribonucleoproteins with biotinylated oligonucleotides via an RNA aptamer for precise gene editing.Intracellular immunization against HIV infection with an intracellular antibody that mimics HIV integrase binding to the cellular LEDGF protein.Query the merits of embryo editing for reproductive research now.Xenotransplantation: back to the future?Genome editing reveals a role for OCT4 in human embryogenesis.CRISPR Becomes Clearer.The Potential of Nanotechnology in Medically Assisted Reproduction.Generation of knock-in cynomolgus monkey via CRISPR/Cas9 editing.Preimplantation genetic testing: current challenges and future prospects.Correction of diverse muscular dystrophy mutations in human engineered heart muscle by single-site genome editing.Molecular biology at the cutting edge: A review on CRISPR/CAS9 gene editing for undergraduates.Responsible innovation in human germline gene editing: Background document to the recommendations of ESHG and ESHRE.Mind the gaps! Towards an ethical framework for genome editing.The Impact of CRISPR/Cas9 Technology on Cardiac Research: From Disease Modelling to Therapeutic Approaches.What Do We Really Think About Human Germline Genome Editing, and What Does It Mean for Medicine?Parenting in the Age of Preimplantation Gene Editing.Renaissance, reinvention, or rhetoric: mitochondria in reproductive medicine 2017.Genome editing technologies and their potential to treat neurologic disease.The Council of Europe and the prohibition on human germline genome editing.Notable advances 2017.Why the way we look at things in reproductive medicine is changing.Glucocorticoid Signaling in Health and Disease: Insights From Tissue-Specific GR Knockout Mice.Better beings?The Skin(ny) on Regenerating the Largest Organ to Save a Patient's Life.Outer Limits of Biotechnologies: A Jewish Perspective.The year in cardiology 2017: heart failure.CRISPR: Established Editor of Human Embryos?
P2860
Q40077901-81C9DE4C-6353-4269-9B3B-352230C5B6D4Q41919375-B2FCEF0B-C3C9-486E-AC29-6E8BBCC457C2Q44877018-CA349358-BA40-49F9-9F4B-8B59A3438E00Q45873745-8FEBCF35-E7B4-408C-A946-A49067770F05Q45874266-A8DB8D81-3BAE-4DD4-82D2-4706C96BDA83Q45875285-7BD364BD-14AD-43D7-867F-F9BF0DDE267DQ46124667-667CEEAD-89A5-4B9A-9F00-EA914D3F4054Q46208205-1E15C879-8D79-43A0-8586-A34C7AC5FABAQ46236955-F0BC03DD-A764-4198-BFBE-B8448121EE33Q46254865-4FC40D27-FE0E-4422-9F7A-409AC5E87979Q46262974-D518103B-AFF9-42B3-A748-08793DD0811FQ46681707-08B65432-ED07-4675-A896-573677AA53F9Q47094135-599279EC-24DB-41DA-AF49-5EFE166A680BQ47106725-89931238-5FA3-41CE-AA22-27603F47D0DAQ47152351-2BB239DE-5FAA-44F6-B713-86E8860842FEQ47184441-A45B2B4E-A76D-4056-B848-082C77E4524BQ47279794-AAC356E3-ADDC-4C0E-86FF-D973CE0B707AQ47625824-48E42BBE-653E-4E99-AF58-BBE82E423693Q47644045-55C0D26F-0349-4314-8EF5-A21CB7441C16Q47708723-9B1F6D7D-8594-4894-AD68-456819BEFFF0Q47868055-84D914A2-7F88-4870-B565-4F0C22AAFE84Q47893009-A0DACBBE-6F85-4B90-9A51-06350425A356Q48041681-DD9804CF-B905-4070-8EA4-70523D11147BQ48142398-82A7015D-204C-4BF8-A07A-E558306E3E2CQ48257215-0E004D06-67A2-4310-BB6E-EC0FFA4EB5DDQ49327272-B99AD6D1-DECF-4EE4-A28C-0BF411427994Q49432567-5F81877F-92C0-4804-9B9D-0EB87781E133Q49643153-EB7412A6-40F4-4999-B77B-03AA638441A0Q49679154-770947CD-9F59-4312-B399-C9F59D6ED420Q49685598-61E95B3B-3D1A-416A-AB82-6D195943867DQ49984648-28E77E87-5D2E-4D5D-86DD-E1E9C18E63B7Q49988530-8B2264AD-5B8A-415D-83AE-B614A65ECD6CQ50030341-38EEDF83-BF71-4DC4-BF29-FCD5E3863E3AQ50056972-C29C70C5-BCB7-4BC1-9522-ED1D46258722Q50065331-89E01BAA-2340-42F3-A43F-8FB2D353BF31Q50093502-3FF14417-8048-4968-B086-BC95B732F500Q50168833-D35B0C99-2942-4DC0-968D-035761FC8BC6Q50181083-81B8DACF-23BF-4596-A7D4-C104615E5B17Q50193302-8E008A5C-45E0-4792-B3B8-752FBEE6E2B9Q50196918-5D5E32BA-5919-4C54-8584-5C18DFA3F6C1
P2860
Correction of a pathogenic gene mutation in human embryos.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Correction of a pathogenic gene mutation in human embryos.
@en
Correction of a pathogenic gene mutation in human embryos.
@nl
type
label
Correction of a pathogenic gene mutation in human embryos.
@en
Correction of a pathogenic gene mutation in human embryos.
@nl
prefLabel
Correction of a pathogenic gene mutation in human embryos.
@en
Correction of a pathogenic gene mutation in human embryos.
@nl
P2093
P2860
P356
P1433
P1476
Correction of a pathogenic gene mutation in human embryos.
@en
P2093
A-Reum Park
Crystal Van Dyken
Daesik Kim
David Battaglia
David M Lee
Diana H Wu
Don P Wolf
Dongmei Ji
Eunju Kang
P2860
P2888
P304
P356
10.1038/NATURE23305
P407
P577
2017-08-02T00:00:00Z